Christine A. Ciunci, MD, MSCE

Dr. Ciunci is a medical oncologist at the Hospital at the Abramson Cancer Center in Philadelphia, Pennsylvania. Her clinical expertise is in thoracic malignancies, including pleural mesothelioma and lung cancer. Dr. Ciunci is part of the multidisciplinary team for the Penn Lung Cancer Program, the Penn Mesothelioma Program, and the Penn Pleural Disease Program. She

Jonathan Thompson, MD

Dr. Thompson is a medical oncologist who treats patients diagnosed with lung cancer, pleural mesothelioma, thymoma, and thymic tumors. He practices at the Froedtert Hospital Cancer Center, affiliated with the Medical College of Wisconsin in Milwaukee, Wisconsin.  Education and Career Dr. Thompson earned his medical degree at the Medical College of Wisconsin and completed his

Alberto Chiappori, MD

Dr. Alberto A. Chiappori is a medical and thoracic oncologist at the Moffitt Cancer Center and Research Institute in Tampa, Florida. He is a Senior Member of Oncology and Medicine for the Thoracic Oncology Program. He specializes in treating patients diagnosed with lung cancer and pleural mesothelioma, as well as pleural neoplasms. Education and Career

Michael Shafique, MD

Dr. Michael Shafique is a thoracic oncologist at the Moffitt Cancer Center in Tampa, Florida. He specializes in treating patients with lung cancer, pleural mesothelioma, neuroendocrine tumors, Pancoast tumors, and thymomas, as well as gynecologic malignancies. Education and Career Dr. Shafique earned his undergraduate degree in Finance at the Wharton School of the University of

Alexander I. Spira, MD, PhD, FACP

Dr. Alexander I. Spira is a medical oncologist and thoracic specialist at Virginia Cancer Specialists, a Fairfax, Virginia multidisciplinary practice of medical oncologists, hematologists, surgeons, palliative care physicians, nurse practitioners, and other professionals. He is also a researcher with leadership roles at Virginia Cancer Specialists. Education and Career Dr. Spira earned his medical degree from

Gregory Michael Lubiniecki, MD

Dr. Gregory Michael Lubiniecki is a medical oncologist who specialized in treating patients with lung cancer and pleural mesothelioma but is now focused on research. He currently oversees cancer research at Merck & Company. Education and Career Dr. Lubiniecki earned his medical degree at Johns Hopkins University in Baltimore, Maryland. He then completed his internship

Antoinette J. Wozniak, MD, FACP, FASCO

Dr. Antoinette J. Wozniak is a medical oncologist and Chief Scientific Officer of the Lung Cancer Research Foundation. She also served as leader of the Lung Cancer Disease Center and Associate Director for Clinical Research in the division of Hematology and Oncology at the University of Pittsburgh, UPMC Hillman Cancer Center in Pittsburgh, Pennsylvania. She

Frank V. Fossella, MD

Dr. Frank V. Fossella is a thoracic medical oncologist and researcher at the University of Texas MD Anderson Cancer Center in Houston, Texas. He has been providing expert patient care to patients diagnosed with mesothelioma and lung cancer for almost 50 years and has distinguished himself through research seeking treatment options that deliver improved patient

Misako Nagasaka, MD, PhD

Dr. Misako Nagasaka is an accomplished thoracic oncologist and clinical researcher whose use of novel drug protocols has made a significant difference for her lung cancer and mesothelioma patients, as well as for those diagnosed with thyroid cancer. She practices at the UCI Health Chao Family Comprehensive Cancer Center in Orange, California. Education and Career

John Wrangle, MD, MPH

Dr. John Wrangle is a thoracic medical oncologist who specializes in treating lung cancer as well as other thoracic malignancies at the Medical University of South Carolina (MUSC). As a researcher, he is dedicated to bringing novel combination immunotherapy treatments to patient care and has developed precision medicine protocols to create additional options for patients.

Get Help Contacting Mesothelioma.net
This field is for validation purposes and should be left unchanged.
24/7 Live Chat
Online Now